GLP-1 clinical trials in Wisconsin: 7 recruiting now

7 GLP-1 clinical trials are recruiting at 7 sites in 4 cities across Wisconsin. Every site below is listed with its city and, where the sponsor publishes one, the number to call.

Every study recruiting in Wisconsin

1. PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

   Phase 4. Run by Brigham and Women's Hospital. Registry number NCT05390892.

   A study testing whether a GLP-1 medicine, semaglutide, can help people lower blood sugar.

   Who can join. Adults 40 to 80, have type 2 diabetes.

   1 site in Wisconsin

   • Medical College of Wisconsin, Milwaukee. 414-805-8104

2. Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled

   Phase 4. Run by Medical College of Wisconsin. Registry number NCT07111494.

   A study testing whether a GLP-1 medicine can help people ease psoriatic arthritis.

   Who can join. Adults 18+, have psoriatic arthritis.

   1 site in Wisconsin

   • Medical College of Wisconsin/Froedtert Hosptial, Milwaukee. 414-955-7040

3. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative

   Phase 3. Run by Eli Lilly and Company. Registry number NCT06937086.

   A study testing whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.

   Who can join. Adults 18 to 70, have ulcerative colitis, BMI 27+.

   1 site in Wisconsin

   • Wisconsin Center for Advanced Research, Milwaukee. 414-908-6500

4. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity

   Phase 3. Run by Eli Lilly and Company. Registry number NCT06937099.

   A study testing whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.

   Who can join. Adults 18 to 70, have Crohn's disease, BMI 27+.

   1 site in Wisconsin

   • Wisconsin Center for Advanced Research, Milwaukee. 414-908-6500

5. Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

   Phase 3. Run by VA Office of Research and Development. Registry number NCT07218354.

   A study testing whether a GLP-1 medicine, semaglutide, can help people with alcohol use disorder drink less.

   Who can join. Adults 18 to 80, have alcohol use disorder, BMI 21+.

   1 site in Wisconsin

   • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison. 608-280-7084

6. A Clinical Study to Compare Efficacy and Safety of Two Different Doses of CagriSema and Semaglutide in Participants With Obesity

   Phase 3. Run by Novo Nordisk A/S. Registry number NCT07564414.

   A study testing whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

   Who can join. Adults 18+, have obesity, BMI 35+.

   1 site in Wisconsin

   • Prevea Health, Green Bay

7. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

   Phase 3. Run by Boehringer Ingelheim. Registry number NCT07754461.

   A study testing whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

   Who can join. Adults 18+, have type 2 diabetes, BMI 23+.

   1 site in Wisconsin

   • Clinical Investigation Specialists, Inc.-Kenosha-69111, Kenosha. 833-602-2368

Source: ClinicalTrials.gov, the federal registry, read September 4, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this siteLinkedInContact